VALYSTR · Stock research
Listed on NYSE. What the market is pricing into Novartis (NVS) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Pharmaceuticals · market value about $301B · P/E 30.4 · revenue $57.4B (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows